IQVIA Holdings Inc. (IQV) Financials

IQV Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 29.7 billion 23.3 billion
Dec. 31, 2025 29.9 billion 23.3 billion
Sept. 30, 2025 28.7 billion 22.4 billion
June 30, 2025 28.6 billion 22.8 billion

IQV Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 618.0 million 65.0 million
Dec. 31, 2025 561.0 million 60.0 million
Sept. 30, 2025 1.2 billion 55.0 million
June 30, 2025 292.0 million 60.0 million

IQV Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 275.0 million
Dec. 31, 2025 514.0 million
Sept. 30, 2025 332.0 million
June 30, 2025 266.0 million

IQV Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 1.9 billion 232.0 million 232.0 million
Dec. 31, 2025 2.1 billion 14.1 billion 225.0 million
Sept. 30, 2025 2.0 billion 12.8 billion 233.0 million
June 30, 2025 2.2 billion 14.2 billion 210.0 million

IQV Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 169.8 million
Dec. 31, 2025 171.9 million
Sept. 30, 2025 171.7 million
June 30, 2025 173.2 million

IQV Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 127.0 million - 502.0 million -
Dec. 31, 2025 174.0 million - 468.0 million -
Sept. 30, 2025 293.0 million - 514.0 million -
June 30, 2025 151.0 million - 509.0 million -

IQV Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 4.2 billion 2.8 billion
Dec. 31, 2025 4.4 billion 4.1 billion
Sept. 30, 2025 4.1 billion 2.7 billion
June 30, 2025 4.0 billion 2.7 billion

IQV Revenue by Segment

Graph available only for paid members. Upgrade to see it.

IQV

Price: $182.05

52 week price:
134.65
247.05

Payout Ratio Range:
-358.43%
6064.86%

Earnings Per Share: 8.04 USD

P/E Ratio: 22.23

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 286158

Market Capitalization: 29.8 billion

Links: